{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:08:14Z","timestamp":1780045694973,"version":"3.53.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.humpath.2026.106114","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:58:15Z","timestamp":1775098695000},"page":"106114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spatially-resolved CD8+ and CD34+ computational immunohistochemistry indicators improve post-nephrectomy risk stratification in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"173","author":[{"given":"Mantas","family":"Fabijonavicius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausra","family":"Garnelyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dovile","family":"Zilenaite-Petrulaitiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Rasmusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Drachneris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertas","family":"Cekauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliksas","family":"Jankevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvydas","family":"Laurinavicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106114_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.humpath.2026.106114_bib3","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1200\/JCO.2002.05.111","article-title":"Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma","volume":"20","author":"Zisman","year":"2002","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106114_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(05)66077-6","article-title":"A postoperative prognostic nomogram for renal cell carcinoma","volume":"166","author":"Kattan","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib5","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","article-title":"An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score","volume":"168","author":"Frank","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib6","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.3390\/ijms24054615","article-title":"Radiogenomics in renal cancer management\u2014current evidence and future prospects","volume":"24","author":"Ferro","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2026.106114_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/MOU.0000000000000813","article-title":"Pathomics in urology","volume":"30","author":"Schuettfort","year":"2020","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib8","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.19.00107","article-title":"Predicting renal cancer recurrence: defining limitations of existing prognostic models with prospective trial-based validation","volume":"37","author":"Correa","year":"2019","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106114_bib9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2026.106114_bib10","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2026.106114_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2026.106114_bib12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1158\/2159-8290.CD-19-0499","article-title":"Tumor microenvironment dynamics in clear cell renal cell carcinoma","volume":"9","author":"Vuong","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2026.106114_bib13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2026.106114_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106114_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1158\/2326-6066.CIR-18-0377","article-title":"Automated analysis of lymphocytic infiltration, tumor budding, and their spatial relationship improves prognostic accuracy in colorectal cancer","volume":"7","author":"Nearchou","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.humpath.2026.106114_bib16","first-page":"5132","article-title":"Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity","volume":"61","author":"Nakano","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2026.106114_bib17","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1158\/1078-0432.CCR-16-2848","article-title":"Tumor-infiltrating and peripheral blood T-cell immunophenotypes predict early relapse in localized clear cell renal cell carcinoma","volume":"23","author":"Giraldo","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106114_bib18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1158\/0008-5472.CAN-16-0274","article-title":"Tim-3 expression on tumor-infiltrating PD-1+CD8+ T cells correlates with poor clinical outcome in renal cell carcinoma","volume":"77","author":"Granier","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2026.106114_bib19","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00262-020-02563-2","article-title":"Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients","volume":"69","author":"Qi","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.humpath.2026.106114_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri.2016.80","article-title":"Regulatory circuits of T cell function in cancer","volume":"16","author":"Speiser","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humpath.2026.106114_bib21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ajpath.2020.01.018","article-title":"Immunogradient indicators for antitumor response assessment by automated tumor-stroma interface zone detection","volume":"190","author":"Rasmusson","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2026.106114_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11255-019-02285-0","article-title":"The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results","volume":"52","author":"Selvi","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.humpath.2026.106114_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/intimm\/dxw021","article-title":"Rational bases for the use of the immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients","volume":"28","author":"Kirilovsky","year":"2016","journal-title":"Int Immunol"},{"key":"10.1016\/j.humpath.2026.106114_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fonc.2019.00439","article-title":"Prognostic value of the neo-immunoscore in renal cell carcinoma","volume":"9","author":"Guo","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2026.106114_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41379-021-00982-9","article-title":"Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes","volume":"35","author":"Ohe","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106114_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1078-0432.CCR-17-1555","article-title":"Tumor microvessel density as a prognostic marker in high-risk renal cell carcinoma patients treated on ECOG-ACRIN E2805","volume":"24","author":"Jilaveanu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106114_bib27","first-page":"116","article-title":"ERG and nestin: useful markers of immature vessels and novel prognostic markers in renal cell carcinoma","volume":"14","author":"Han","year":"2021","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2026.106114_bib28","first-page":"130","article-title":"Microvessel area of immature vessels is a prognostic factor in renal cell carcinoma","volume":"21","author":"Sato","year":"2014","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"key":"10.1016\/j.humpath.2026.106114_bib29","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.bjc.6603796","article-title":"High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT\u2013PCR mRNA expression profile","volume":"96","author":"Baldewijns","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2026.106114_bib30","first-page":"5855","article-title":"Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis","volume":"7","author":"Cheng","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2026.106114_bib31","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.7150\/jca.27408","article-title":"Immunoscore system for predicting clinical outcome of metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors","volume":"9","author":"Yao","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.humpath.2026.106114_bib32","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"Goel","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.humpath.2026.106114_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/apm.12649","article-title":"CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma","volume":"125","author":"L\u00f3pez","year":"2017","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2026.106114_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2026.106114_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2026.106114_bib36","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jamaoncol.2019.2311","article-title":"Multiomics prediction of response rates to therapies to inhibit programmed cell death 1 and programmed cell death 1 ligand 1","volume":"5","author":"Lee","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.humpath.2026.106114_bib37","article-title":"Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states","volume":"4","author":"Nyman","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.humpath.2026.106114_bib38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","article-title":"Integrated proteogenomic characterization of clear cell renal cell carcinoma","volume":"179","author":"Clark","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2026.106114_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.humpath.2026.106114_bib40","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.humpath.2026.106114_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the \u201cImmunoscore\u201d in the classification of malignant tumours","volume":"232","author":"Galon","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2026.106114_bib42","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106114_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106114_bib44","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/sj.bjc.6601331","article-title":"Clinical significance of immune cell infiltration within gallbladder cancer","volume":"89","author":"Nakakubo","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2026.106114_bib45","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1245\/s10434-019-07529-y","article-title":"Prognostic role of the immunoscore for patients with urothelial carcinoma of the bladder who underwent radical cystectomy","volume":"26","author":"Li","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106114_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205746","article-title":"Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy","volume":"13","author":"Yu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2026.106114_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12967-023-04336-8","article-title":"Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma","volume":"21","author":"Zhang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.humpath.2026.106114_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006195","article-title":"Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma","volume":"11","author":"Chakiryan","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2026.106114_bib49","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s11255-020-02592-x","article-title":"Prognostic value of immunological profile based on CD8+ and FoxP3+ T lymphocytes in the peritumoral and intratumoral subsites for renal cell carcinoma","volume":"52","author":"Teke","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.humpath.2026.106114_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11302-017-9596-x","article-title":"CD39-adenosinergic axis in renal pathophysiology and therapeutics","volume":"14","author":"Kishore","year":"2018","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.humpath.2026.106114_bib51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.humpath.2026.106114_bib52","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/cancers15041205","article-title":"CD8+ cell density gradient across the tumor epithelium\u2013stromal interface of non-muscle invasive papillary urothelial carcinoma predicts recurrence-free survival after BCG immunotherapy","volume":"15","author":"Drachneris","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2026.106114_bib53","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s13277-013-1367-x","article-title":"Lack of association of microvessel density with prognosis of renal cell carcinoma: evidence from meta-analysis","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"key":"10.1016\/j.humpath.2026.106114_bib54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/labinvest.2011.153","article-title":"Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study","volume":"92","author":"Iakovlev","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2026.106114_bib55","article-title":"Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial","author":"Jasti","year":"2024","journal-title":"ArXiv"},{"key":"10.1016\/j.humpath.2026.106114_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.12388","article-title":"Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma","volume":"10","author":"Kaneko","year":"2024","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.humpath.2026.106114_bib57","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41419-023-06119-x","article-title":"Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications","volume":"14","author":"Fang","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.humpath.2026.106114_bib58","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00432-021-03895-x","article-title":"Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review","volume":"148","author":"Chen","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106114_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm6388","article-title":"Tumors resurrect an embryonic vascular program to escape immunity","volume":"7","author":"Huijbers","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.humpath.2026.106114_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune-vascular crosstalkfor cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humpath.2026.106114_bib61","article-title":"Tumor-specific but immunosuppressive CD39+CD8+ T cells exhibit double-faceted roles in clear cell renal cell carcinoma","volume":"6","author":"Lee","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.humpath.2026.106114_bib62","doi-asserted-by":"crossref","unstructured":"Li Y, Wang Z, Jiang W, et al. Tumor-infiltrating TNFRSF9+ CD8+ T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response. OncoImmunology n.d.;9:1838141. https:\/\/doi.org\/10.1080\/2162402X.2020.1838141.","DOI":"10.1080\/2162402X.2020.1838141"},{"key":"10.1016\/j.humpath.2026.106114_bib63","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.eururo.2018.01.005","article-title":"Predicting oncologic outcomes in renal cell carcinoma after surgery","volume":"73","author":"Leibovich","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib64","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1097\/01.ju.0000165693.68449.c3","article-title":"Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy","volume":"173","author":"Lam","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib65","unstructured":"EAU guidelines. Edn. presented at the EAU annual Congress Paris 2024. ISBN 978-94-92671-23-3. n.d."},{"key":"10.1016\/j.humpath.2026.106114_bib66","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00345-013-1071-x","article-title":"Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database","volume":"31","author":"May","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13293-023-00540-9","article-title":"Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8+ T-cells highly infiltrated in males","volume":"14","author":"Ning","year":"2023","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.humpath.2026.106114_bib68","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2015.02.2943","article-title":"Surgical management for local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy","volume":"194","author":"Thomas","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib69","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bju.13620","article-title":"Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes","volume":"119","author":"Psutka","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2026.106114_bib70","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-5347(05)67350-8","article-title":"Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy","volume":"164","author":"Itano","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2026.106114_bib71","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s11255-021-02966-9","article-title":"Management of local recurrence after radical nephrectomy: surgical removal with or without systemic treatment is still the gold standard. Results from a multicenter international cohort","volume":"53","author":"Marchioni","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.humpath.2026.106114_bib72","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa2312695","article-title":"Overall survival with adjuvant pembrolizumab in renal-cell carcinoma","volume":"390","author":"Choueiri","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106114_bib73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jama.2016.18977","article-title":"Revised CIOMS international ethical guidelines for health-related research involving humans","volume":"317","author":"van Delden","year":"2017","journal-title":"JAMA"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:23:29Z","timestamp":1780043009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"alternative-id":["S0046817726000833"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106114","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatially-resolved CD8+ and CD34+ computational immunohistochemistry indicators improve post-nephrectomy risk stratification in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106114"}}